Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Damier

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
The New England Journal of Medicine|November 14, 2008
Subthalamic nucleus stimulation in severe obsessive-compulsive disorderLuc Mallet, Mircea Polosan, Nematollah Jaafari, et al.
CNS Drugs|May 25, 2025
Motor and Non-motor Complications Following Different Early Therapies in Parkinson's Disease: Longitudinal Analysis of Real-Life Clinical and Therapeutic Data from the French NS-PARK CohortAymeric Lanore, Edouard Januel, Nathalie Bertille, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 29, 2025
Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK)Olivier Rascol, Fabienne Ory-Magne, Wassilios G Meissner, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 5, 2024
Amantadine use in the French prospective NS-Park cohortMargherita Fabbri, Vanessa Rousseau, Jean-Christophe Corvol, et al.
The New England Journal of Medicine|April 10, 2024
Trial of Lixisenatide in Early Parkinson's DiseaseWassilios G Meissner, Philippe Remy, Caroline Giordana, et al.
Neurology|February 10, 2019
Quality of life predicts outcome of deep brain stimulation in early Parkinson diseaseW M Michael Schuepbach, Lisa Tonder, Alfons Schnitzler, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 3, 2022
Results of a Randomized Clinical Trial of Speech After Early Neurostimulation in Parkinson's DiseaseSerge Pinto, Adelheid Nebel, Jörn Rau, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
The New England Journal of Medicine|November 14, 2008
Subthalamic nucleus stimulation in severe obsessive-compulsive disorderLuc Mallet, Mircea Polosan, Nematollah Jaafari, et al.
CNS Drugs|May 25, 2025
Motor and Non-motor Complications Following Different Early Therapies in Parkinson's Disease: Longitudinal Analysis of Real-Life Clinical and Therapeutic Data from the French NS-PARK CohortAymeric Lanore, Edouard Januel, Nathalie Bertille, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 29, 2025
Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK)Olivier Rascol, Fabienne Ory-Magne, Wassilios G Meissner, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 5, 2024
Amantadine use in the French prospective NS-Park cohortMargherita Fabbri, Vanessa Rousseau, Jean-Christophe Corvol, et al.
The New England Journal of Medicine|April 10, 2024
Trial of Lixisenatide in Early Parkinson's DiseaseWassilios G Meissner, Philippe Remy, Caroline Giordana, et al.
Neurology|February 10, 2019
Quality of life predicts outcome of deep brain stimulation in early Parkinson diseaseW M Michael Schuepbach, Lisa Tonder, Alfons Schnitzler, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 3, 2022
Results of a Randomized Clinical Trial of Speech After Early Neurostimulation in Parkinson's DiseaseSerge Pinto, Adelheid Nebel, Jörn Rau, et al.
Pageof 11